Over the next five years the mRNA Vaccines & Therapeutics market will register a 28.70% CAGR in terms of revenue, the global market size will reach USD 1161.8 million by 2027.
In 2027, the global mRNA vaccine and therapeutic market is expected to be worth USD 1161.7 million. One of the significant factors driving the market's growth is the rising prevalence of chronic and infectious diseases such as diabetes, HIV, cancer, and CVDs. The increasing demand for therapeutic medications and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV), and other viral illnesses, as well as the traditional vaccination approach's inability to find vaccines at vital times, are now all contributing to market expansion. mRNA vaccines and therapeutics are generated with the use of modern technologies that are more effective against infections, have improved immunogenicity, and need less expense to produce than conventional pharmaceuticals. Furthermore, advancements in lipid nanoparticle formulations for in-vivo systemic distribution of mRNA are boosting market growth prospects.
The report aspects discussed the profile of the top manufacturers of the global mRNA Vaccines & Therapeutics market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined mRNA Vaccines & Therapeutics Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The mRNA Vaccines & Therapeutics Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market includes Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology and others.
MODERNA ANNOUNCES FIRST PARTICIPANTS DOSED IN PHASE 1/2 STUDY WITH MRNA-1020 AND MRNA-1030 SEASONAL INFLUENZA VACCINE CANDIDATES
April 11, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the first participants have been dosed in the Phase 1/2 study of the Company's seasonal influenza vaccine candidates, mRNA-1020 and mRNA-1030. This Phase 1/2 randomized, observer-blind, dose-ranging study will evaluate the safety, reactogenicity and immunogenicity of a single dose of mRNA-1020 or mRNA-1030 in healthy adults 18 years and older in the U.S. The mRNA-1020 and mRNA-1030 candidates each include eight mRNAs, targeting both hemagglutinin and neuraminidase at different doses and ratios
mRNA Vaccines & Therapeutics Market provides details by vendors, including company total revenue (financials), company overview, market potential, global presence, his business report briefly talks about market performance of each business sector covering growth factors and sales volume. this analysis provides the This mRNA Vaccines & Therapeutics Market analysis report provides recent trends, granular level data covering market size and share. It provides all the recent updates about CORONA virus and its impact on world economy and human health. By getting this data, key players can obtain profit making and right business opportunities for future growth. Its further guides to increase the product demand and business expansion.
By Type, it is segmented into
By Applications it is segmented into
By End-User's
North America is dominating the mRNA vaccine & therapeutics market, due to the presence of major players, growing research & development on this topic, and the present Covid-19 pandemic situation. The North American market was worth of USD 215.7 million in 2019, expected to reach USD 1106.8 million in 2026 with CAGR of 27.78% in the forecasting period.
The mRNA Vaccines & Therapeutics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global mRNA Vaccines & Therapeutics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes
|
Report Details |
Forecast Period 2022 to 2027 CAGR |
CAGR of 28.70% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies
| Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology |
Regions Covered
|
|
Countries Covered |
|
Base Year
|
2022 |
Historical Year
|
2017 to 2021 |
Forecast Year
| 2022 to 2027 |
Number of Pages
| 93
|
Customization Available
|
Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The mRNA Vaccines & Therapeutics Market is studied from 2017 - 2027.
What is the growth rate of mRNA Vaccines & Therapeutics Market?
The mRNA Vaccines & Therapeutics Market is growing at a CAGR of 28.70% over the next 5 years.
Who are the key players in mRNA Vaccines & Therapeutics Market?
Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
What region does this mRNA Vaccines & Therapeutics Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of mRNA Vaccines & Therapeutics Market?
Infectious Disease, Cancer, Other
What are the major end-use applications of mRNA Vaccines & Therapeutics Market?
Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine
Application_List
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.
